Scarica l'app Stockscreener
16.44
3.18%
-0.54
Precedente Chiudi:
$16.98
Aprire:
$16.42
Volume 24 ore:
10,013
Relative Volume:
0.44
Capitalizzazione di mercato:
$1.17B
Reddito:
$376.88M
Utile/perdita netta:
$2.52M
Rapporto P/E:
542.57
EPS:
0.0303
Flusso di cassa netto:
$49.32M
1 W Prestazione:
-2.84%
1M Prestazione:
-1.08%
6M Prestazione:
+24.91%
1 anno Prestazione:
+83.48%
Intervallo 1D:
$16.42
$16.77
Intervallo di 1 settimana:
$16.36
$16.98
Portata 52W:
$8.60
$21.34
Pharming Group Nv Adr Stock (PHAR) Company Profile
Nome
Pharming Group Nv Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare PHAR vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHAR
Pharming Group Nv Adr
|
16.50 | 1.20B | 376.88M | 2.52M | 49.32M | 0.0303 |
VRTX
Vertex Pharmaceuticals Inc
|
424.88 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
709.60 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
799.60 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.45 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
295.57 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pharming Group Nv Adr Stock (PHAR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-12-09 | Iniziato | Jefferies | Buy |
Pharming Group Nv Adr Borsa (PHAR) Ultime notizie
Pharming Group gears up to report Q4 earnings: What's in the cards? - MSN
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Decline in Short Interest - MarketBeat
Pharming Group to report first quarter 2026 financial results and provide business update on May 7 - GlobeNewswire Inc.
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Large Decline in Short Interest - MarketBeat
Pharming Group (NASDAQ:PHAR) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Pharming Group N.V. Investigated by the Portnoy Law Firm - GlobeNewswire
Pharming (NASDAQ: PHAR) updates 20-F with corrected CEO/CFO certifications - Stock Titan
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Up 33.9% in March - MarketBeat
Pharming Group (NASDAQ:PHAR) Given Buy Rating at HC Wainwright - defenseworld.net
PHARM.AS Stock Price, Quote & Chart | PHARMING GROUP NV (AMS:PHARM) - ChartMill
HC Wainwright Estimates Pharming Group Q3 Earnings - Defense World
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Growth in Short Interest - MarketBeat
HC Wainwright Predicts Pharming Group Q1 Earnings - MarketBeat
A2QLQY Stock Price and Chart — LS:A2QLQY - TradingView
Pharming Group reports Q4 revenue of $106.5m, reaffirms 2026 guidance - Investing.com India
Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards? - Finviz
Pharming Group Prepares to Announce Q4 Results: What Can Investors Expect? - Bitget
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Drop in Short Interest - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V.PHAR - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - GlobeNewswire Inc.
FY2025 EPS Estimates for Pharming Group Increased by Analyst - Defense World
Pharming shares surge as 2026 guidance tops analyst expectations - Investing.com
Pharming Group stock tumbles after FDA issues Complete Response Letter - Investing.com
Pharming Group (NASDAQ:PHAR) Sets New 1-Year HighTime to Buy? - MarketBeat
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update - MarketBeat
Pharming Group stock hits 52-week high at 18.6 USD - Investing.com
Pharming Group (NASDAQ:PHAR) Cut to Hold at Zacks Research - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap Down After Analyst Downgrade - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap DownHere's What Happened - MarketBeat
Pharming Group (NASDAQ:PHAR) Trading Up 4.4% – Here’s Why - Defense World
Pharming Group (NASDAQ:PHAR) Hits New 1-Year High – Still a Buy? - Defense World
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Rises By 102.0% - MarketBeat
Pharming Group stock hits 52-week high at 18.19 USD - Investing.com
Best Momentum Stocks to Buy for Dec. 22 - Yahoo Finance Singapore
Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Hits New 12-Month HighShould You Buy? - MarketBeat
Operating expenses (excl. COGS) of Pharming Group NV Sponsored ADR – LSX:A2QLQY - TradingView
Pharming Group (NASDAQ:PHAR) Stock Price Up 11%Time to Buy? - MarketBeat
Pharming Group Nv Adr Azioni (PHAR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
2.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):